- Home
- ARVN vs ANDE Comparison
ARVN vs ANDE Comparison
Compare ARVN & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- ANDE
- Stock Information
- Founded
- ARVN 2015
- ANDE 1947
- Country
- ARVN United States
- ANDE United States
- Employees
- ARVN N/A
- ANDE N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- ANDE Farming/Seeds/Milling
- Sector
- ARVN Health Care
- ANDE Industrials
- Exchange
- ARVN Nasdaq
- ANDE Nasdaq
- Market Cap
- ARVN 1.4B
- ANDE 1.4B
- IPO Year
- ARVN 2018
- ANDE N/A
- Fundamental
- Price
- ARVN $17.77
- ANDE $45.53
- Analyst Decision
- ARVN Strong Buy
- ANDE Buy
- Analyst Count
- ARVN 12
- ANDE 1
- Target Price
- ARVN $58.82
- ANDE $55.00
- AVG Volume (30 Days)
- ARVN 1.1M
- ANDE 283.9K
- Earning Date
- ARVN 02-11-2025
- ANDE 02-18-2025
- Dividend Yield
- ARVN N/A
- ANDE 1.71%
- EPS Growth
- ARVN N/A
- ANDE 12.93
- EPS
- ARVN N/A
- ANDE 3.32
- Revenue
- ARVN $263,399,999.00
- ANDE $11,257,548,000.00
- Revenue This Year
- ARVN N/A
- ANDE N/A
- Revenue Next Year
- ARVN $1.63
- ANDE $6.60
- P/E Ratio
- ARVN N/A
- ANDE $13.71
- Revenue Growth
- ARVN 235.54
- ANDE N/A
- 52 Week Low
- ARVN $16.61
- ANDE $39.25
- 52 Week High
- ARVN $51.51
- ANDE $61.46
- Technical
- Relative Strength Index (RSI)
- ARVN 44.33
- ANDE 61.24
- Support Level
- ARVN $17.19
- ANDE $40.00
- Resistance Level
- ARVN $20.38
- ANDE $51.58
- Average True Range (ATR)
- ARVN 1.38
- ANDE 1.50
- MACD
- ARVN 0.08
- ANDE 0.70
- Stochastic Oscillator
- ARVN 30.77
- ANDE 49.46
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About ANDE Andersons Inc. (The)
Andersons Inc is diversified company with its main focus in agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment which generates the majority of the revenue is engaged in movement of physical commodities such as; whole grains, grain products, feed ingredients and domestic fuel products among other agricultural commodities. Geographically, the company generates majority of its revenue from United States and rest from Canada, Mexico, Egypt, Switzerland and other markets.